UNSPSC 51284119: Ceftriaxone

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75J73V1629. European Medicines Agency schedules Ceftriaxone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07431MIG. Ceftriaxone generally arises in the molecular formula C18H18N8O7S3.

UNSPSC 51284119 Ceftriaxone is a Commodity code identifying a specific antibiotic pharmaceutical product, yet recent state and local solicitations tagged with this code show little activity directly aligned with ceftriaxone procurement. Instead, the opportunities named under the code involve broader pharmaceutical and medical supply acquisitions—naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, direct-to-manufacturer prescription programs, and emergency medical supplies for fire rescue operations. State and local governments buying under this code span county health departments, state pharmacy benefit programs, municipal fire departments, and cooperative purchasing alliances serving multiple jurisdictions. The mix reflects fragmented demand across different types of healthcare and emergency-response end users rather than a concentrated buyer base.

Recent activity appears primarily in Florida and Minnesota, with secondary engagement from Texas and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, requiring vendors to supply through three authorized wholesalers and meet cGMP and Drug Supply Chain Security Act certification. The City of Tampa's Purchasing Department posted an IFB on March 25, 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with a March 13, 2026 deadline and an estimated contract value of $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries required and a July 26, 2023 response deadline. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs, indicating preliminary state-level interest in restructuring pharmaceutical procurement channels outside traditional pharmacy benefit manager and group purchasing organization arrangements.